Skip to main content
. 2017 Aug;29(4):351–360. doi: 10.21147/j.issn.1000-9604.2017.04.08

4.

4

Disease-free survival (A) and overall survival (B) analyses between patients whose anatomic stage III cancer was down-staged to prognostic stage II [ana-III (pro-II) group] and patients whose anatomic stage III cancer remained prognostic stage III [ana-III (pro-III) group].